PharmaShots Weekly Snapshots (June 03 – June 07, 2024)

Share this

PharmaShots Weekly Snapshots (June 03 – June 07, 2024)

This week PharmaShots’ news was all about the updates on M&A, Pharma, Clinical Trials, Regulatory & MedTech. Check out our full report below:

GSK Highlights P-III (DREAMM-8) Study Data of Blenrep Plus Pomalidomide and Dexamethasone for R/R Multiple Myeloma at ASCO 2024

Read More: GSK                                                                                                           

Eli Lilly Highlights the P-I/II Trial Data of Olomorasib for Treating Advanced Solid Tumors at ASCO 2024

Read More: Eli Lilly                                                                                                    

Pfizer Reports the P-III (ECHELON-3) Trial Results of Adcetris for Treating R/R Diffuse Large B-cell Lymphoma (DLBCL)

Read More: Pfizer                                                                                                          

Sanofi Highlights the P-III (IMROZ) Study Data of Sarclisa for Newly Diagnosed Transplant-Ineligible Multiple Myeloma

Read More: Sanofi                                                                                                    

BMS Highlights Data from three P-III Studies of Breyanzi to Treat Various B-Cell Malignancies at ASCO 2024

Read More: BMS                                                                                                           

BMS Features the P-III (CheckMate -9DW) Trial Data of Opdivo Plus Yervoy for Treating Advanced Hepatocellular Carcinoma at ASCO 2024

Read More: BMS                                                                                                            

The USPTO Issues Notice of Allowance for New Patent Covering MediciNova’s Ibudilast (MN-166) to Prevent Metastasis of Multiple Solid Tumors

Read More: MediciNova                                                                                             

Gilead Reports Data from the P-III (ASSURE) Trial of Seladelpar for Treating Primary Biliary Cholangitis

Read More: Gilead                                                                                                        

AbbVie Reports Advancement of ABBV-383 to P-III Study for the Treatment of Multiple Myeloma

Read More: AbbVie                                                                                                  

Amgen Reports the P-III (MITIGATE) Study Data of Uplizna (Inebilizumab-cdon) to Treat Immunoglobulin G4-Related Disease (IgG4-RD)

Read More: Amgen                                                                                                       

AbbVie Reports the P-II (PICCOLO) Study Data of Elahere (Mirvetuximab Soravtansine) for Treating Ovarian Cancer

Read More: AbbVie                                                                                                       

Boehringer Ingelheim Reports Additional Data from the P-II Study of Survodutide to Treat Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Read More: Boehringer Ingelheim                                                                            


AstraZeneca’s Tagrisso Receives the CHMP’s Positive Opinion for Treating EGFR-Mutated advanced Lung Cancer

Read More: AstraZeneca                                                                                              

CStone Pharmaceuticals’ Cejemly Receives the CHMP’s Positive Opinion for Treating NSCLC

Read More: CStone Pharmaceuticals                                                                         

NeoImmuneTech’s Efineptakin Alfa (NT-I7) Receives the EMA’s Orphan Drug Designation to Treat Acute Radiation Syndrome

Read More: NeoImmuneTech                                                                                    

Saghmos Therapeutics Receives the US Patent for ST-62516 to Reduce the Risk of Acute Kidney Injury

Read More: Saghmos Therapeutics                                                                           

Geron’s Rytelo (Imetelstat) Gains the US FDA’s Approval to Treat Myelodysplastic Syndromes (MDS) with Transfusion-Dependent Anemia

Read More: Geron                                                                                                         


Immutep Partners with Merck to Conduct P-III Study of Eftilagimod Alfa (Efti) with Keytruda for Treating NSCLC

Read More: Immutep & Merck                                                                                 

FibroGen Collaborates with Regeneron to Assess FG-3165 and FG-3175 Plus Libtayo for Treating Solid Tumors

Read More: FibroGen & Regeneron                                                                          

BlueSphere Bio and the National Cancer Institute Team Up to Develop Therapies for Rare Respiratory Disease

Read More: BlueSphere Bio & National Cancer Institute                                    

ArriVent BioPharma Collaborates with Alphamab to Develop Antibody Drug Conjugates for Treating Cancers

Read More: ArriVent BioPharma & Alphamab                                                     


HighLife’s TSMVR System Obtains the US FDA’s IDE Approval to Commence Clinical Trial for Treating Mitral Regurgitation

Read More: HighLife                                                                                                       

Evolution Optiks Gains the US FDA’s 510(k) Clearance for Eye Examination Device

Read More: Evolution Optiks                                                                                      

The US FDA Grants Clearance to Moon Surgical’s Commercial Maestro Robotic Surgery System

Read More: Moon Surgical                                                                                         

Abbott’s AVEIR Dual Chamber Leadless Pacemaker System Gains CE Mark to Treat Abnormal or Slow Heart Rhythms

Read More: Abbott                                                                                                      


Stryker Acquires Artelon, Enhancing its Portfolio of Soft Tissue Fixation Solutions

Read More: Stryker & Artelon                                                                                     

BD Reports the Acquisition of Edwards Lifesciences' Critical Care Product Group, Enhancing its Smart Connected Care Solutions

Read More: BD & Edwards Lifesciences                                                                 

GSK Acquires Elsie Biotechnologies to Advance Oligonucleotide Platform and Pipeline Therapies

Read More: GSK & Elsie Biotechnologies                                                               


Ventyx Biosciences Reports Preclinical Data of VTX3232 in Murine Diet-Induced Obesity Models

Read More: Ventyx Biosciences                                                                              


Zomedica Highlights the Data of TRUFORMA Research to Diagnose Thyroid Disease in Cats at ACVIM 2024

Read More: Zomedica               

Related Post: PharmaShots Weekly Snapshots (May 27 – May 31, 2024)                                                                                  

Disha Nankani

Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions